Coronary Artery Bypass Graft Surgery

The American Heart Association has issued its heart disease and stroke statistical update for 2025, which provides an overview of statistics related to CVD, stroke and CV risk factors.

CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in Medicare beneficiaries, a speaker reported.

A percutaneous approach to treatment of severe aortic stenosis and complex CAD was superior to surgical valve replacement and CABG, a speaker reported.

Despite larger declines in STEMI and non-STEMI events from 2011 to 2018, women received proportionately fewer revascularization procedures and had a higher STEMI mortality rate vs. men, researchers reported.

The price of coronary artery bypass graft surgery varies widely across the U.S., with investor-owned and major teaching hospitals conferring greater cost, researchers reported.

High lipoprotein(a), a relatively common finding in patients undergoing CABG, was associated with increased risk for all-cause death after surgery, researchers reported.

Implementation of a CT angiography-derived fractional flow reserve program on a national level was associated with reduced risk for mortality and fewer downstream CV tests at 2 years, according to the results of the FISH&CHIPS study.

The Patient-Centered Outcomes Research Institute has awarded nearly $30 million to fund a trial program comparing CABG vs. PCI in women and people from historically underrepresented races and ethnicities with coronary artery disease.

Among patients who underwent CABG, those who attended cardiac rehabilitation were more likely to survive at 2 years compared with those who were not, researchers reported.

Statin-loading therapy at 12 and 2 hours before CABG — although safe and well tolerated — demonstrated no significant clinical benefit compared with placebo, researchers reported.